Adaptimmune Therapeutics plc (ADAPY)
OTCMKTS · Delayed Price · Currency is USD
0.0350
-0.0030 (-7.89%)
Jul 10, 2026, 11:22 AM EST
Adaptimmune Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 25.21 | -71.88 | -113.87 | -165.46 | -158.09 |
Depreciation & Amortization | 11.28 | 15.91 | 9.84 | 6.08 | 6.57 |
Other Amortization | 0.02 | 0.08 | - | - | - |
Loss (Gain) From Sale of Assets | -142.42 | - | - | - | - |
Asset Writedown & Restructuring Costs | 10.15 | 10.4 | - | - | - |
Loss (Gain) From Sale of Investments | - | - | -1.99 | 2.53 | 5.28 |
Stock-Based Compensation | -1.16 | 10.92 | 11.77 | 18.24 | 20.63 |
Other Operating Activities | 9.1 | 36.36 | -21.68 | -1.62 | 1.71 |
Change in Accounts Receivable | -14.03 | -4 | -1.29 | -9.81 | -19.36 |
Change in Inventory | -3.68 | -7.36 | - | - | - |
Change in Accounts Payable | -9.54 | 9.94 | -9.09 | 4.41 | 4.21 |
Change in Unearned Revenue | -6.68 | -69.8 | -14.57 | 3.87 | 149.79 |
Change in Other Net Operating Assets | -0.16 | 0.3 | - | - | - |
Operating Cash Flow | -121.91 | -69.12 | -140.88 | -141.77 | 10.73 |
Capital Expenditures | -0.39 | -0.89 | -4.68 | -29.5 | -8.57 |
Sale of Property, Plant & Equipment | 50.58 | - | - | - | - |
Cash Acquisitions | - | - | 45.26 | - | - |
Sale (Purchase) of Intangibles | - | -1.02 | -0.2 | -0.24 | -0.21 |
Investment in Securities | 60.86 | -56.36 | 135.03 | 118.88 | 84.58 |
Other Investing Activities | 0.22 | 1.09 | 1.12 | - | - |
Investing Cash Flow | 111.27 | -57.18 | 176.54 | 89.14 | 75.8 |
Long-Term Debt Issued | - | 49.5 | - | - | - |
Long-Term Debt Repaid | -55.56 | -4.91 | - | - | - |
Net Debt Issued (Repaid) | -55.56 | 44.59 | - | - | - |
Issuance of Common Stock | 1.84 | 29.25 | 0.88 | 12.87 | 3.29 |
Financing Cash Flow | -53.72 | 73.84 | 0.88 | 12.87 | 3.29 |
Foreign Exchange Rate Adjustments | -0.83 | -0.4 | 0.88 | -2.3 | 0.37 |
Net Cash Flow | -65.19 | -52.85 | 37.42 | -42.06 | 90.18 |
Free Cash Flow | -122.3 | -70 | -145.56 | -171.27 | 2.16 |
Free Cash Flow Margin | -2064.40% | - | -241.47% | -630.86% | 35.05% |
Free Cash Flow Per Share | -0.45 | -0.28 | -0.72 | -1.06 | 0.01 |
Cash Interest Paid | 8.81 | 4.18 | - | - | - |
Cash Income Tax Paid | -12.57 | -41.37 | 4 | 0.63 | 0.54 |
Levered Free Cash Flow | -61.61 | -69.03 | -69.17 | -111.24 | -75.01 |
Unlevered Free Cash Flow | -57.07 | -64.92 | -69.17 | -111.24 | -75.01 |
Change in Working Capital | -34.08 | -70.91 | -24.95 | -1.53 | 134.63 |